In this journal club episode, we break down the draft of the Chronic Urticaria Guidelines: 2026 AAAAI/ACAAI Joint Task Force (JTF) on Practice Parameters GRADE- and Institute of Medicine-based recommendations. We explain what counts as chronic hives, why the guideline leans on second-generation non-drowsy antihistamines, what to do when those are not enough, and what is new for both adults and kids.

At the time of recording, the draft was open for comments; it closed for comments on June 30, 2026.

What we cover in our episode about the new chronic hives guidelines

  • What chronic hives are: A plain-language look at the two main types, spontaneous and inducible, plus angioedema (swelling) that can come with them.
  • What a draft guideline is: Why the guideline is still being reviewed, and how comments can help shape it before it is final.
  • What's new for kids: How children fit into the guideline, and why most do well without advanced treatments.
  • The antihistamine shift: Why the guideline favors non-drowsy, second-generation antihistamines and moves away from older, sedating ones.
  • When antihistamines are not enough: If higher-dose antihistamines do not work, the recommended advanced option is to start omalizumab (Xolair) plus two newer additions: dupilumab (Dupixent) and remibrutinib (Rhapsido).

Download Infographic

More hive resources 

***********

The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.

***********

Made in partnership with The Allergy & Asthma Network.

Thanks to Opella for sponsoring today’s episode. 

This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Itch: Allergies, Asthma & Immunology. Innehållet i podden är skapat av The Itch: Allergies, Asthma & Immunology och inte av, eller tillsammans med, Poddtoppen.